Sperm and genetics study for men with hodgkin lymphoma
Part of Cancer clinical trials.
This study looks at how chemotherapy for Hodgkin lymphoma affects sperm health. By comparing sperm before and after treatment, researchers hope to learn more about fertility risks and how to protect future fertility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 45 years old.
- You have been diagnosed with Hodgkin lymphoma.
- You have not yet received any chemotherapy or other cancer treatment.
- Your treatment plan is 4 to 6 cycles of ABVD or BrECADD chemotherapy.
- You are covered by the French social security system.
- You will not receive radiation to your abdomen.
- You agree to participate in the research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls adults with Hodgkin or non-Hodgkin lymphoma who plan to receive chemotherapy aimed at cure. It may help doctors better understand outcomes and how lymphoma care is managed over time.
This study looks at fertility outcomes in young men who had cancer or blood disorders as children and then received high-risk treatment that can affect future fertility. It also compares people who did or did not store testicular tissue through a biopsy when they were younger.
This study looks at how treatments that can harm ovaries or testicles (like certain chemotherapy, radiation, and immune therapies) may affect fertility. It may help you and others by measuring hormone levels (and in some cases sperm) before and during/after treatment.
This study examines testicular function and semen quality in men who were treated for cancer before age 18 and are now in remission. It aims to understand how childhood cancer treatments affect long-term fertility.
This trial tests a new treatment where your own immune cells are modified to better attack Hodgkin lymphoma cells. It is for people whose disease has not responded to other therapies.
This study collects leftover tissue samples from patients with or without lymphoma to help researchers better understand lymph system cancers. It may be an option if you are already having a biopsy or surgery.
Hear when a new Hodgkin Disease Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.